感染疾病診斷市場：依技術、疾病（腹瀉疾病、呼吸道感染疾病、血液感染疾病、性行為感染）、最終用戶及地區分類

Infectious Disease Diagnostics Market, By Technology, By Disease Indication, Diarrheal Disease,Respiratory Infections,Blood Infections,STDs, By End User, By Geography

出版日期: 2026年04月01日 | 出版商:

Coherent Market Insights | 英文 160 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到2026年，感染疾病診斷市場規模將達到19.261億美元，2033年將達到37.557億美元。預計從2026年到2033年，該市場將以10.0%的複合年成長率成長。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	19.261億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	10.00%	2033年市場規模預測：	37.557億美元

感染疾病是由細菌、病毒、真菌和寄生蟲等微生物引起的，並且可以在不同物種之間傳播。感染疾病透過直接接觸或間接途徑（例如昆蟲叮咬、食物、土壤、水和空氣等媒介）在人與人之間傳播。診斷這些疾病包括識別病原體及其類型，並確定感染程度。診斷是發現疾病的第一步，而治療則是感染疾病疾病的關鍵。感染疾病是導致發病率和死亡率的主要原因。診斷在確定任何臨床治療方案中都起著至關重要的作用。雖然感染疾病診斷有助於診斷由病原體引起的疾病，但像愛滋病、結核病、瘧疾和流感等感染疾病的盛行率很高，可以透過使用疾病特異性診斷測試進行有效診斷。傳統的感染疾病診斷方法耗時較長。這促使快速、準確、便攜的即時檢測產品在感染疾病診斷市場中湧現。即時檢測能夠在患者附近快速診斷感染疾病，並提供即時結果。目前，許多研究人員正致力於開發多種即時診斷技術。這些診斷測試中使用的技術可分為生化方法、分子生物學方法、免疫診斷、傳統培養方法和染色方法。生化方法包括酵素免疫分析法（ELISA）和凝集反應，而分子生物學方法包括聚合酵素鏈鎖反應（PCR）和次世代定序技術。這些測試具有高處理能力，能夠準確診斷感染疾病。

市場動態

預計在預測期內，感染疾病診斷市場的擴張將推動市場成長，而這主要得益於人們對早期診斷重要性的認知不斷提高。例如，根據美國疾病管制與預防中心 (CDC) 1995 年的報告，美國每年因醫院感染 (HAI) 導致的感染疾病達 170 萬例，死亡病例達 9.9 萬例。其中，尿道感染佔所有醫療相關感染疾病的比例最高 (32%)，其次是手術部位感染 (22%)、肺炎 (15%) 和血流感染疾病(14%)。

本次調查的主要特點

本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和核准、區域前景以及主要參與者採取的競爭策略。
本研究根據以下參數介紹了全球感染疾病診斷市場主要參與者的概況：公司概況、財務表現、產品系列、企業發展區域、分銷策略、主要發展、策略和未來計劃。
透過利用本報告中的見解，企業負責人和經營團隊將能夠就未來的產品發布、技術升級、市場擴張和行銷策略做出明智的決策。
這份全球感染疾病診斷市場報告的目標受群眾外包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師等產業相關人員。
相關人員可以透過利用市場分析中使用的各種策略矩陣來簡化決策過程。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第8章競爭情勢

Becton Dickinson & Company
Cepheid, Inc.
Abbott Laboratries
BioMerieux
Hologic, Inc.
Danaher Corportion
Thermo Fisher Scientific, Inc.
Roche Diagnostics
DiaSorin SpA
Quidel Corporation
Bio-Rad Laboratories, Inc

第9章

調查方法
關於本公司

簡介目錄

Product Code: CMI1971

Infectious Disease Diagnostics Market is estimated to be valued at USD 1,926.1 Mn in 2026 and is expected to reach USD 3,755.7 Mn by 2033, growing at a compound annual growth rate (CAGR) of 10.0% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 1,926.1 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	10.00%	2033 Value Projection:	USD 3,755.7 Mn

Infectious diseases are caused by organisms such as bacteria, virus, fungi, and parasites and are capable of transmission from one species to another species. Infectious diseases spread from person to person either through direct contact or indirectly through insect bites or other vectors like food, soil, water, and air. Diagnosis of these diseases involves identifying the pathogen and its type and then diagnose infection has spread. Diagnosis is the initial step of discovering a disease and its treatment leads to elimination of infectious diseases. Infectious diseases are among the leading causes of morbidity and death. Diagnostics plays important part in deciding the course of any clinical treatment. While Infectious diseases diagnostics help in diagnosing disease caused because of pathogenic disease Infectious diseases such as HIV, tuberculosis, malaria, and Influenza are highly prevalent and can be efficiently diagnosed with the help of diagnostic tests available for the respective diseases. Traditional infectious disease diagnosis was time-consuming. Because of this factor, the Infectious Disease Diagnostics Market has seen the emergence of rapid, accurate, and portable point-of-care testing products. Point of care testing helps for faster diagnosis of infectious diseases nearby to the patient's location and provides immediate results. Several researchers are now working on multiplex point-of-care diagnostic technologies. Technologies utilized by these diagnostic tests are classified into biochemical techniques, molecular techniques, immunodiagnostics, conventional culturing, and staining techniques. Biochemical techniques include Enzyme-linked Immunosorbent Assay (ELISA), agglutination, and others, while molecular techniques include Polymerase Chain Reaction (PCR) and Next-Generation Sequencing techniques. These tests are capable of diagnosing the infectious diseases accurately with high throughput capacity.

Market Dynamics

Increasing prevalence of Infectious Disease Diagnostics Market is expected to drive the market growth over the forecast period, due to growing awareness for the early disease diagnostics. For instance, In 1995, According to the Centers for Disease Control and Prevention {CDCP}, Hospital-acquired infections( HAIs) in American hospitals are responsible for 1.7 million infections and 99,000 deaths occur per year. Out of all, the urinary tract infections occurs up to 32% of all the healthcare-acquired infections, followed by surgical site infections [22%], pneumonia [15%], and bloodstream infections [14%].

Key features of the study

It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
It profiles leading players in the global infectious disease diagnostics market based on the following parameters -company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include Becton Dickinson & Company, Cepheid, Inc., Abbott Laboratories, BioMerieux SA, Hologic, Inc., Danaher Corporation, Thermo Fisher Scientific, Inc., Roche Diagnostics, Alera Inc., DiaSorin S.p.A., Quidel Corporation, and Bio-Rad Laboratories, Inc.
Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
Global infectious disease diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.

Market Segmentation

Technology Insights (Revenue, USD Mn & KT, 2026 - 2033)
ELISA
Polymerase Chain Reaction
Immunoassays
Cell Cultures
Others
Disease Indication Insights (Revenue, USD Mn & KT, 2026 - 2033)
Central nervous system (CNS) Infection
- Meningitis
- Brain Abscess
Diarrheal Disease
- Shigellosis
- Cholera
- Enteric/Typhoid Fever
Respiratory Infections
- Tuberculosis
- Influenza
- Bronchitis
Blood Infections
- Malaria
- Dengue
- Infectious Mononucleosis
- Others
STDs
- Chlamydia
- AIDS
- Syphilis
- Others
End User Insights (Revenue, USD Mn & KT, 2026 - 2033)
Hospitals
Diagnostics centers
Dermatology Clinics
Others (Research Institutes, Specialty Centres, etc.)
Regional Insights (Revenue, USD Mn & KT, 2026 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East & Africa
- GCC Countries
- Israel
- Rest of Middle East & Africa
Key Players Insights
Becton Dickinson & Company
Cepheid, Inc
Abbott Laboratories
BioMerieux SA
Hologic, Inc
Danaher Corporation
Thermo Fisher Scientific, Inc
Roche Diagnostics
DiaSorin S.p.A
Quidel Corporation
Bio-Rad Laboratories

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Technology
- Market Snapshot, By Disease Indication
- Market Snapshot, By End Users
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Attractiveness Analysis
- Market Opportunities
- Product Launches
- Merger, Acquisition, Collaborations
Regulatory Guideline and Compliances
Key Developments
PEST Analysis

4. Global Infectious Disease Diagnostics Market, By Technology, 2021-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
ELISA
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Segment Trends
Polymerase Chain Reaction (PCR)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Segment Trends
Immunoassays
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Segment Trends
Cell Cultures
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Segment Trends
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Segment Trends

5. Global Infectious Disease Diagnostics Market , By Disease Indication 2021 - 2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Central Nervous System Infections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
  - Meningitis
  - Brain Abscess
Diarrheal Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
  - Shigellosis
  - Cholera
  - Enteric/Typhoid Fever
Respiratory Infections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
  - Tuberculosis
  - Influenza
  - Bronchitis
Blood Infections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
  - Malaria
  - Dengue
  - Infectious Mononucleosis
  - Others
Sexually transmitted diseases (STDs),
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
  - Chlamydia
  - AIDS
  - Syphilis
  - Others

6. Global Infectious Disease Diagnostics Market , By End Users 2021 - 2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segments Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Dermatology Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Others (Research Institutes, Specialty Centers, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

7. Global Infectious Disease Diagnostics Market , By Region, 2021-2033, (USD Mn)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2021 - 2033
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, Technology , 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology , 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication , 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology , 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication , 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021- 2033, (USD Mn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology , 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication , 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology , 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication , 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology , 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication , 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (USD Mn)
  - North Africa
  - Central Africa
  - South Africa

8. Competitive Landscape

Becton Dickinson & Company
- Company Overview
- Product Portfolio
- Key Development
- Financial Performance
- Strategies
Cepheid, Inc.
- Company Overview
- Product Portfolio
- Key Development
- Financial Performance
- Strategies
Abbott Laboratries
- Company Overview
- Product Portfolio
- Key Development
- Financial Performance
- Strategies
BioMerieux
- Company Overview
- Product Portfolio
- Key Development
- Financial Performance
- Strategies
Hologic, Inc.
- Company Overview
- Product Portfolio
- Key Development
- Financial Performance
- Strategies
Danaher Corportion
- Company Overview
- Product Portfolio
- Key Development
- Financial Performance
- Strategies
Thermo Fisher Scientific, Inc.
- Company Overview
- Product Portfolio
- Key Development
- Financial Performance
- Strategies
Roche Diagnostics
- Company Overview
- Product Portfolio
- Key Development
- Financial Performance
- Strategies
DiaSorin S.p.A.
- Company Overview
- Product Portfolio
- Key Development
- Financial Performance
- Strategies
Quidel Corporation
- Company Overview
- Product Portfolio
- Key Development
- Financial Performance
- Strategies
Bio-Rad Laboratories, Inc
- Company Overview
- Product Portfolio
- Key Development
- Financial Performance
- Strategies